Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$19,434,249
+$2,627,344 QoQ
Shares Held
153,825
+27.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#327
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$405,042
PutShares
3,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $485,897,181 across 15 Drug Manufacturers - General names. GILD ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,252 | $137,037,286 | |
| 2 | ABBV |
AbbVie Inc.
|
459,683 | $115,674,628 | |
| 3 | JNJ |
Johnson & Johnson
|
392,685 | $99,730,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
378,859 | $48,683,381 | |
| 5 | AMGN |
Amgen Inc
|
77,970 | $28,234,494 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
153,825 | $19,434,249 | |
| 7 | PFE |
Pfizer Inc
|
421,273 | $10,144,251 | |
| 8 | AZN |
Astrazeneca PLC
|
41,103 | $7,793,949 |
All Filings in GILD
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,434,249 | 153,825 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $16,806,905 | 120,592 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $15,141,695 | 123,364 | Shares | Defined | 2026-02-10 | |
| 2025-12-31 | $405,042 | 3,300 | Put | Sole | 2026-02-10 | |
| 2025-09-30 | $366,300 | 3,300 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $13,455,531 | 121,221 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $365,871 | 3,300 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $7,407,223 | 66,810 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $7,803,833 | 69,646 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,888,955 | 63,754 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,952,762 | 59,074 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,988,298 | 58,130 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,381,447 | 59,815 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,253,672 | 52,508 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,873,273 | 51,685 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,445,027 | 44,700 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $6,629,717 | 79,905 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,069,661 | 82,349 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,790,119 | 29,018 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $552,890 | 8,945 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $655,674 | 11,029 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $793,554 | 10,929 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $767,511 | 10,988 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $3,094,361 | 44,937 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,983,837 | 46,168 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,757,937 | 30,174 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,278,892 | 83,540 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,642,856 | 73,341 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,867,355 | 24,978 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||